1. Home
  2. BMBL vs VALN Comparison

BMBL vs VALN Comparison

Compare BMBL & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bumble Inc.

BMBL

Bumble Inc.

N/A

Current Price

$2.74

Market Cap

417.4M

Sector

Technology

ML Signal

N/A

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$5.45

Market Cap

495.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BMBL
VALN
Founded
2014
2012
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.4M
495.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
BMBL
VALN
Price
$2.74
$5.45
Analyst Decision
Hold
Strong Buy
Analyst Count
13
2
Target Price
$4.46
$15.50
AVG Volume (30 Days)
2.8M
26.9K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$965,658,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$93.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$4.75
52 Week High
$7.32
$12.25

Technical Indicators

Market Signals
Indicator
BMBL
VALN
Relative Strength Index (RSI) 42.88 64.67
Support Level $2.66 $5.55
Resistance Level $3.21 $6.69
Average True Range (ATR) 0.16 0.17
MACD -0.03 0.08
Stochastic Oscillator 23.62 71.51

Price Performance

Historical Comparison
BMBL
VALN

About BMBL Bumble Inc.

Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: